News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Dana-Farber – Changing how outcomes of clinical trials are shared with patients by publishing summaries of trials
dana-farber.org
Nov 30, 2024, 15:58

Dana-Farber – Changing how outcomes of clinical trials are shared with patients by publishing summaries of trials

Dana-Farber shared on X:

“The Breast Oncology Program is changing how outcomes of clinical trials are shared with patients by publishing summaries of trials led by Dana-Farber Cancer Institute. ”

Additional information.

Dana-Farber - Changing how outcomes of clinical trials are shared with patients by publishing summaries of trials

cancer Dana-Farber Dana-Farber Cancer Institute OncoDaily Oncology The Breast Oncology Program
Special Coverage
Drugs
Nov 30, 2024, 16:22
Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC
Insight
Nov 30, 2024, 16:17
Vivek Subbiah: The development of immunotherapy in MSI-H and D-MMR cancers by Thierry Andre et al.
Blog
Nov 30, 2024, 16:13
Maria Navarro: Adapting WHO’s GBCI framework to Cali’s unique context
Blog
Nov 30, 2024, 16:08
Pembrolizumab followed by irreversible electroporation of a liver metastasis in Pancreatic Cancer patients
Blog
Nov 30, 2024, 16:06
Tedros Adhanom Ghebreyesus: Meeting with Foreign and Trade Minister Péter Szijjártó
Blog
Nov 30, 2024, 16:01
IL-15 to enhance the effectiveness of GPC3-targeting CAR T cells in solid tumors
Blog
Nov 30, 2024, 15:58
Dana-Farber - Changing how outcomes of clinical trials are shared with patients by publishing summaries of trials
Blog
Nov 30, 2024, 15:56
ESMO - Insights on salary disparities, female authorship, and leadership representation in oncology
Insight
Nov 30, 2024, 15:56
Single stage direct -to- implant breast reconstruction following mastectomy - Maher Hassan
Insight
Nov 30, 2024, 15:51
Myeloma Paper of the Day, November 30th, suggested by Robert Orlowski
Insight
Nov 30, 2024, 15:27
Obe-cel CAR T Therapy Achieves High Response Rates in R/R B-cell ALL: FELIX Trial Results
Insight
Nov 30, 2024, 15:23
Emad Shash: Access and Equity for Better Patient Care